Each vial contains Retatrutide 10MG and Tirzepatide 20MG. Supplied as a set of 10 research vials.
Contact online support for real-time help with product selection, bulk orders, shipping, or payment.
One clear reference point for this compound, its format, and the supplied product information.
Retatrutide 10MG + Tirzepatide 20MG per vial. Pack size: 10 vials.
Reta+Tirz brings retatrutide and tirzepatide together in one clearly identified research configuration. It is intended for laboratories comparing multi-pathway incretin models, response curves, and analytical behavior under controlled study conditions.
Retatrutide is investigated for combined GLP-1, GIP, and glucagon receptor activity, while tirzepatide is studied as a dual GIP and GLP-1 receptor agonist. Examining the two references together can support work on pathway overlap, receptor selectivity, and experimental design without implying a clinical outcome.
Retatrutide 10 + Tirzepatide 20
Keep sealed, protected from direct light, and under conditions appropriate to the individual components and the laboratory's validated procedures. Record lot identity and handling conditions throughout the study.
Research use only. Not for human consumption, diagnostic use, or therapeutic application.
Key answers before shipping, dispatch, and after-sales details.
Worldwide delivery in 8–15 days with air dispatch on business days.
Tracking provided on every order.
Invalid test results → Full refund.
Dedicated support team with clear pre- and post-payment updates.
Brazil orders require CPF/CNPJ for local tax handling.
Contact our online support for real-time communication about products, orders, shipping, payment, or bulk supply.